Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Hits & Misses
    • Artificial Intelligence and Healthcare
    • Doctors & Hospitals
      • COVID-19 and Public Health
    • Policy & Legislation
      • Affordable Care Act
    • Health Economics & Costs
      • Cost of Healthcare
      • Drug Prices & Regulations
      • Health Reform
    • Health Insurance
      • Public Insurance
      • Medicare
    • Telemedicine
      • Medical Tourism
  • Goodman Institute
  • Contact
  • Search
The Goodman Institute Health Blog

Category: Health Insurance

Cancer Drug Doses Could be Safely Lowered, Saving Money, Reducing Side Effects

Posted on August 20, 2026 by Devon Herrick

Cancer therapy is often an excruciating process with numerous debilitating side effects. It is also expensive. Yet, the U.S. Food and Drug Administration (FDA) approves dose and regimens of cancer drugs that are longer – and more costly – than what some experts say is necessary.

+

Thursday Links – 20 August 2026

Posted on August 20, 2026August 19, 2026 by John C. Goodman
  • America is experiencing its biggest prescription drug price deflation in generations.
  • The good news: New CMS guidance requires Medicaid and CHIP, Medicare Advantage and exchange insurers to post certain metrics, such as a list of all services requiring prior authorization, to the plans’ public-facing websites in an easily accessible location.
  • The bad news: More needs to be done.
  • Two approaches to fixing Medicaid.
  • Why have prescription drug prices seen the biggest drop in 60 years?
  • LLMs size you up. If it thinks you are low socioeconomic status and you ask about travel options, it may filter out more expensive flights – without you asking it!
+

Wednesday Links – 19 August 2026

Posted on August 19, 2026August 18, 2026 by John C. Goodman
  • Medicare Advantage plans give enrollees an average of $2,660 per member  for benefits not available from traditional Medicare.
  • Study: Nearly one-third of all women ages 20 to 44 will have heart disease in 2050, up from one-fourth today. 
  • Study: More than half of patients with metastatic lung cancer don’t receive life-extending treatments.
  • A 2012 randomized controlled trial sponsored by the federal government found that children assigned to Head Start showed transient improvements in language and literacy during preschool. But “these early effects rapidly dissipated in elementary school,” the study found, and participants performed no better academically by third grade.
  • The French lilac, a garden plant that was used to treat diabetes for centuries became the blueprint for metformin.
+

GLP-1 Weight Loss Drugs Are Truly Wonder Drugs

Posted on August 16, 2026August 15, 2026 by Devon Herrick

The new class of weight loss drugs, glucagon-like peptide-1 receptor agonists (GLP-1), were originally developed to treat diabetes. Along the way something curious began to happen. People lost weight and lost their desire to gorge on food.

+
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • …
  • 247
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 45 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom